Barry Dvorchik

Daptomycin Pharmacokinetics and Safety following Administration of Escalating Doses Once Daily to Healthy Subjects

Barry Dvorchik, D J Brazier, Michael F. DeBruin et al. · Antimicrobial Agents and Chemotherapy · 2003 · 357 citations · Full text

Drug Safety, Healthy Subjects, Antibiotics +15

Population Pharmacokinetics of Daptomycin

Barry Dvorchik, Robert D. Arbeit, Julia Chung et al. · Antimicrobial Agents and Chemotherapy · 2004 · 154 citations · Full text

Antibiotic Adjuvant, Pharmacotherapy, Population Pharmacokinetics +17

Smoking-induced changes in nicotine disposition: Application of a new HPLC assay for nicotine and its metabolites

Gabriel A. Kyerematen, Michael D Damiano, Barry Dvorchik et al. · Clinical Pharmacology & Therapeutics · 1982 · 124 citations

Tobacco Cessation, Elimination Half-lifes, Smoking-induced Changes +18

The Pharmacokinetics of Daptomycin in Moderately Obese, Morbidly Obese, and Matched Nonobese Subjects

Barry Dvorchik, David Damphousse · The Journal of Clinical Pharmacology · 2004 · 118 citations

Metabolic Disorder, Daptomycin Pharmacokinetics, Pharmacotherapy +20

Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine

Elliot S. Vesell, G. Thomas Passananti, Patricia A. Glenwright et al. · Clinical Pharmacology & Therapeutics · 1975 · 117 citations